1.【生,化】鸟氨酸
1.“ornithin”的变体
1.The variant of ornithin
1.We discuss two alternative shuttles, an ornithine-citrulline shuttle and a glutamine-glutamate shuttle.
我们讨论两个替代航天飞机，一个鸟氨酸-瓜氨酸接送和谷氨酰胺，谷氨酸接送。
2.Ultimately, House deduces that the patient has OTD (ornithine transcarbamylase deficiency).
最终，豪斯推断病人有OTD（氨酸转移酶缺乏症）。
3.Objective To evaluate the clinical efficacy and safety of L-ornithine-L-aspartate treating the patients with hepatic encephalopathy.
目的应用门冬氨酸鸟氨酸对肝性脑病的临床疗效及安全性进行观察。
4.Large amount of cystine as well as arginine lysine and ornithine are excreted in the urine .
从患者的尿中排出大量的胱氨酸，精氨酸，赖氨酸和鸟氨酸。
5.L- ornithine is a kind of middle metabolizing production, which is not make of protein.
L-鸟氨酸是人体代谢中必不可少的中间代谢产物，一种非蛋白质氨基酸。
6.Objective To study the role of ornithine aspartate on preventing of liver fibrosis through the rat liver fibrotic model.
目的通过大鼠肝纤维化动物模型，研究门冬氨酸鸟氨酸防止肝纤维化的作用。
7.Correlation between the expressions of ornithine decarboxylase and angiogenesis in esophageal squamous cell carcinoma
鸟氨酸脱羧酶与食管鳞癌血管生成相关性的研究
8.Anaesthetic management of a patient with ornithine transcarbamylase deficiency
一例鸟氨酸氨甲酰转移酶缺乏症患者的麻醉管理
9.Relationship Between Ornithine Decarboxylase Expression and Pathological Changes in Ulcerative Colitis at Different Periods
鸟氨酸脱羧酶表达水平与溃疡性结肠炎病变时相的关系
10.Clinical Control Study of L-ornithine-L-aspartate in the Treatment of Subclinical Hepatic Encephalopathy
门冬氨酸鸟氨酸治疗亚临床肝性脑病的临床对照研究